Member Info for smithfields

Https://www.nasdaq.com/market-activity/stocks/ilmn

When does the AZ collaboration period end and we get the the up-date report.?

Surely a buy out would depend on AZ's evaluation of the Phase 11 trial....then possibly moving into Phase 111....When are these results expected to be released?

Https://www.otcmarkets.com/stock/ANPCY/overview

DAILY ADVANCERS (top of the list)

OTCQX Best Market Logo

ANPCY

+ 22.50 %

OTCQX Best Market Logo

UNTCW

+ 22.22 %

OTCQX Best Market Logo

ENZN

+ 19.74 %

OTCQX Best Market Logo

IQST

+ 19.22 %

OTCQX Best Market Logo

LTCN

+ 15.99 %

Momentum taking a breather..

https://www.otcmarkets.com/stock/ANPCY/overview

Is this ours?

https://www.otcmarkets.com/stock/ANPCY/overview

Has the AZ connection been confirmed?

rns extract..

'Researchers used the Parsortix® system to isolate and harvest CTCs from 30 patients with EGFR-mutated NSCLC that were undergoing treatment with osimertinib (TAGRISSO: AstraZeneca). '

Ref to the AZ share slide.....an RNS out to clarify the position....then goes on to explain their priorities with the first in line being...'comercialisation of prescription medicines in oncology......'.....that's us.

05 November 2024

AZN share price movement

As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China.

If requested, we will fully cooperate with the Chinese authorities.

We continue to deliver our life changing medicines to patients in China and our operations are ongoing.

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca

Good find 'workbench'.

https://pmc.ncbi.nlm.nih.gov/articles/PMC6586069/

I'll b buy at 7p and out by Christmas at 15p...thanks

Https://www.msn.com/en-gb/money/other/exclusive-harbour-energy-joins-north-sea-producers-retreat-ahead-of-tax-hikes/ar-AA1sN8Eh?ocid=hpmsn&cvid=ff8004ada9a744dbaa8a213722ea41fc&ei=48

If Insti's lose money, they claim tax relief.if Inti's make money, they pay tax...for them, it's a win, win situation.

Https://www.msn.com/en-gb/health/health-news/1-000-people-are-diagnosed-with-cancer-every-day-in-the-uk-data-shows/ar-AA1ssKyB?ocid=hpmsn&cvid=986e8cf31b2f4779a160fd8e769d58d6&ei=46

Https://www.msn.com/en-gb/health/other/number-of-people-diagnosed-with-cancer-rises-5-in-a-year-figures-show/ar-AA1sr8lO?ocid=hpmsn&cvid=362d2aa10a604faaaa1a50e90d36ca74&ei=48

It beggars belief that the BOD have made no attempt to rescue the falling share price, knowing that the possibilty of a cash call exists.

This is the bit that interests me.......the possible move to Phase 111.

'AstraZeneca DDR drug trials; showing encouraging results and moving to the next stage of testing on patient samples'

That's all well and good EC....nothing wrong with your summation, however, the RNS brings to mind an estate agent trying to sell a dilapidated house claiming....

'Three Large Pharma contracts secured each with substantial revenue potential'

Like AGL.....this lot could 'talk the talk'..but couldn't 'walk the walk'.....it's a cruel world.

https://www.msn.com/en-gb/money/other/shareholders-to-be-wiped-out-as-titanic-shipbuilder-sinks-into-administration/ar-AA1rkBXd?ocid=hpmsn&cvid=f7289f07117341d5b771d64c3e4eaf9a&ei=19

What part of ......'we'll all be wiped out' ....did you not understand?

40% down in the last month.....and that was with 'good ' news. Another month like this and we'll all be wiped out....Lord knows where this will be with 'negative' news.

https://www.londonstockexchange.com/stock/AGL/angle-plc/company-page